$415 Million is the total value of Sio Capital Management, LLC's 71 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VRTX | VERTEX PHARMACEUTICALS INC | $5,177,000 | -0.3% | 28,232 | 0.0% | 1.25% | -11.0% | |
| FOMX | FOAMIX PHARMACEUTICALS LTD | $3,084,000 | -36.5% | 1,295,669 | 0.0% | 0.74% | -43.3% | |
| PFNX | PFENEX INC | $1,440,000 | +9.1% | 213,608 | 0.0% | 0.35% | -2.5% | |
| SENS | SENSEONICS HOLDINGS INC | $1,132,000 | -16.7% | 554,858 | 0.0% | 0.27% | -25.6% | |
| INGN | INOGEN INC | $1,014,000 | -30.0% | 15,189 | 0.0% | 0.24% | -37.6% | |
| AFMD | AFFIMED NV | $769,000 | -31.6% | 267,942 | 0.0% | 0.18% | -39.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS ORD | 24 | Q4 2023 | 8.3% |
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 19 | Q1 2024 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| THE CIGNA GROUP | 17 | Q2 2024 | 11.0% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 14, 2024 | 280,000 | 7.5% |
| Gracell Biotechnologies Inc. | February 14, 2024 | 25,007,900 | 5.2% |
| Modular Medical, Inc. | February 14, 2024 | 2,110,260 | 10.0% |
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-26 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.